Anemia and cost in Medicare patients with congestive heart failure

Craig A Solid1, Robert N Foley, David T Gilbertson

  • 1Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minnesota, Minneapolis, MN 55404, USA.

Insights

Anemia in congestive heart failure (CHF) patients significantly increases Medicare costs. This study found anemia is linked to higher healthcare spending in elderly CHF patients.

Area of Science:

  • Cardiology
  • Geriatrics
  • Health Economics

Background:

  • Anemia is a common comorbidity in patients with congestive heart failure (CHF).
  • The economic burden of anemia in CHF patients on healthcare systems is not well-defined.

Purpose of the Study:

  • To determine the total cost to Medicare associated with anemia in congestive heart failure (CHF) patients.
  • To quantify the increased medical expenditure linked to anemia in elderly CHF patients.

Main Methods:

  • Utilized International Classification of Diseases, Ninth Revision, Clinical Modification codes to identify anemia, CHF, and comorbidities in 2002.
  • Calculated total Medicare costs for 2003 based on identified patient cohorts.
  • Performed statistical analysis to compare costs between CHF patients with and without anemia, adjusting for demographic and comorbidity factors.

Main Results:

  • Anemia was present in 32% of CHF patients, associated with older age, female sex, non-white race, and greater comorbidity burden.
  • CHF patients with anemia incurred higher per-member-per-month costs ($1781.01) compared to those without anemia ($1142.38), a ratio of 1.56.
  • After adjusting for demographic and comorbidity factors, the cost ratio remained significant at 1.25, indicating anemia independently increases healthcare costs.

Conclusions:

  • Anemia is a significant independent predictor of increased healthcare expenditure in elderly patients with congestive heart failure.
  • Addressing anemia in CHF patients may lead to substantial cost savings for Medicare.
  • This study highlights the economic impact of anemia as a comorbidity in chronic heart conditions.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...